Atheromatous plaque from human carotid artery: Potential involvement of the endothelin-1 and their receptors

Process Biochemistry

Volumn 44, Issue 11, 2009, Pages 1231-1236

  Bernal López, M Rosa ^a,d   Rípodas, Ainhoa ^b   Aragoncillo, Paloma ^c   Aguado, Manuel Gil ^c   Hernando, Francisco Javier Serrano ^c   Tinahones, Francisco J ^a   Gómez Huelgas, Ricardo ^a   Fernández Cruz, Arturo ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HCSC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Atherosclerosis; Carotid endarterectomy; Coronary bypass; Endothelin system

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CORONARY BYPASS; ENDOTHELIN; ENDOTHELIN SYSTEM; ENDOTHELIN-1; HEALTHY CONTROLS; HUMAN ATHEROSCLEROSIS; HUMAN CAROTID ARTERY; IMMUNOHISTOCHEMICAL STUDIES; PLASMA LEVELS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELLS;

AMINES; GENE EXPRESSION;

PLASMAS;

EID: 70249120642     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2009.06.022     Document Type: Article

References (30)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature (Lond.) 332 (1988) 411-415
2. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., et al. The human endothelin family: three structurally and pharmacologically distinct isopeptide predicted by three separate genes. Proc Natl Acad Sci USA 86 (1989) 2863-2867
3. Battistini B.J., Chailler P., D'Orleans-Juste P., Brière N.A., and Sirois P. Growth regulatory properties of endothelins. Peptides 14 (1993) 385-399
4. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Himura S., Goto K., et al. Cloning of a cDNA encoding a non-isopeptide selective subtype of endothelin receptor. Nature 348 (1990) 732-735
5. Weis M., Wildhirt S.M., Schulze C., Rieder G., Wilbert-Lampen U., Wolf W.P., et al. Endothelin in coronary endothelial dysfunction early after human heart transplantation. J Heart Lung Transplant 18 11 (1999) 1071-1079
6. A receptor distribution. J Cardiovasc Pharmacol 22 Suppl. 8 (1993) S128-S131
7. B receptors in canine coronary arteries. Circ Res 74 (1994) 105-114
8. Ergul A., Jupin D., Johnson M.H., and Prisant L.M. Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients. J Clin Hypertens (Greenwich) 8 8 (2006) 549-554
9. Sutherland A.J., Nataatmadja M.I., Walker P.J., Cuttle L., Garlick R.B., and West M.J. Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation 113 9 (2006) 1180-1188
10. Woods M., Mitchell J.A., Wood E.G., Barker S., Walcot N.R., Rees G.M., et al. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol Pharmacol 55 5 (1999) 902-909
11. Shirai N., Naruko T., Ohsawa M., Ikura Y., Sugama Y., Hirayama M., et al. Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans. J Hypertens 24 4 (2006) 711-721
12. Ihling C., Szombathy T., Bohrmann B., Brockhaus M., Schaefer H.E., and Loeffler B.M. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104 8 (2001) 864-869
13. Valverde I., Barreto M., and Malaisse W.J. Stimulation by d-glucose of protein biosynthesis in tumoral insulin producing cells (RINm5F line). Endocrinology 122 (1988) 443-1448
14. B) in rat retina. J Neurochem 61 (1993) 1113-1119
15. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., and Burnett Jr. J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325 14 (1991) 997-1001
16. Kanaya A.M., Barrett-Connor E., and Wassel Fyr C.L. Endothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study). Am J Cardiol 99 4 (2007) 486-490
17. Fernández-Cruz A., Patiño R., Ibarra J., Fernández L., Roldán M., Moya J., et al. In: Lüsher T.F. (Ed). Endothelin in Hypertension and Diabetes Mellitus. The Endothelium in Cardiovascular Disease (1995), Springer 157-170
18. Little P.J., Ivey M.E., and Osman N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr Vasc Pharmacol 6 3 (2008) 195-203
19. Solini A., Santini E., Madec S., Cuccato S., and Ferrannini E. Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: possible role in wound healing and tissue repair. Growth Factors 25 6 (2007) 392-399
20. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49 21 (2007) 2129-2138
21. Montero I., Orbe J., Varo N., Beloqui O., Monreal J.I., Rodriguez J.A., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 7 (2006) 1369-1378
22. Budde T., Fechtrup C., Bösenberg E., Vielhauer C., Enbergs A., Schulte H., et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 14 11 (1994) 1730-1736
23. Ariyo A.A., Thach C., and Tracy R. Cardiovascular health study investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 349 22 (2003) 2108-2115
24. Genest J.J., Martin-Munley S.S., McNamara J.R., Ordovas J.M., Jenner J., Myers R.H., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85 6 (1992) 2025-2033
25. Jackson C.D., Barnes K., Homer-Vanniasinkam S., and Turner A.J. Expression and localization of human endothelin-converting enzyme-1 isoforms in symptomatic atherosclerotic disease and saphenous vein. Exp Biol Med (Maywood) 231 6 (2006) 794-801
26. Böhm F., Johansson B.L., Hedin U., Alving K., and Pernow J. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 160 1 (2002) 215-222
27. Winkles J.A., Alberts G.F., Brogi E., and Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 191 3 (1993) 1081-1088
28. Iwasa S., Fan J., Shimokama T., Nagata M., and Watanabe T. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146 1 (1999) 93-100
29. Ross R., Bowen-Pope D.F., and Raines E.W. Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci 327 1239 (1990) 155-169
30. Anggrahini D.W., Emoto N., Nakayama K., Widyantoro B., Adiarto S., Iwasa N., et al. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc Res 82 1 (2009) 143-151